Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:2011:216464.
doi: 10.4061/2011/216464. Epub 2011 Jul 31.

Modulation of tyrosine hydroxylase, neuropeptide y, glutamate, and substance p in Ganglia and brain areas involved in cardiovascular control after chronic exposure to nicotine

Merari F R Ferrari  1 , Emerson F Coelho, Karen L G Farizatto, Gerson Chadi, Debora R Fior-Chadi
Affiliations

Modulation of tyrosine hydroxylase, neuropeptide y, glutamate, and substance p in Ganglia and brain areas involved in cardiovascular control after chronic exposure to nicotine

Merari F R Ferrari et al. Int J Hypertens. 2011.

Abstract

Considering that nicotine instantly interacts with central and peripheral nervous systems promoting cardiovascular effects after tobacco smoking, we evaluated the modulation of glutamate, tyrosine hydroxylase (TH), neuropeptide Y (NPY), and substance P (SP) in nodose/petrosal and superior cervical ganglia, as well as TH and NPY in nucleus tractus solitarii (NTS) and hypothalamic paraventricular nucleus (PVN) of normotensive Wistar Kyoto (WKY) and spontaneously hypertensive rats (SHR) after 8 weeks of nicotine exposure. Immunohistochemical and in situ hybridization data demonstrated increased expression of TH in brain and ganglia related to blood pressure control, preferentially in SHR, after nicotine exposure. The alkaloid also increased NPY immunoreactivity in ganglia, NTS, and PVN of SHR, in spite of decreasing its receptor (NPY1R) binding in NTS of both strains. Nicotine increased SP and glutamate in ganglia. In summary, nicotine positively modulated the studied variables in ganglia while its central effects were mainly constrained to SHR.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Immunoreactivity of tyrosine hydroxylase, neuropeptide Y, glutamate, and substance P in nodose/petrosal ganglia of Wistar Kyoto (WKY) and spontaneously hypertensive (SHR) rats exposed either to nicotine or placebo delivered through subcutaneously implanted pellets during 8 weeks. Values are presented as mean ± SD, *P < 0.05 as compared to the same strain placebo treated rat; #P < 0.05 as compared to WKY on the same experimental condition, according to 2-way ANOVA followed by Bonferroni posttest, n = 6.
Figure 2
Figure 2
Immunoreactivity of tyrosine hydroxylase, neuropeptide Y, and substance P in superior cervical ganglion (SCG) of Wistar Kyoto (WKY) and spontaneously hypertensive (SHR) rats exposed either to nicotine or placebo delivered through subcutaneously implanted pellets during 8 weeks. Values are presented as mean ± SD, *P < 0.05 as compared to the same strain placebo treated rat; #P < 0.05 as compared to WKY on the same experimental condition, according to 2-way ANOVA followed by Bonferroni posttest, n = 6.
Figure 3
Figure 3
Immunoreactivity and mRNA expression of tyrosine hydroxylase in the nucleus tractus solitarii (NTS) and paraventricular hypothalamic nucleus (PVN) of Wistar Kyoto (WKY) and spontaneously hypertensive (SHR) rats exposed either to nicotine or placebo delivered through subcutaneously implanted pellets during 8 weeks. Values are presented as mean ± SD, *P < 0.05 as compared to the same strain placebo-treated rat; #P < 0.05 as compared to WKY on the same experimental condition, according to 2-way ANOVA followed by Bonferroni posttest, n = 6.
Figure 4
Figure 4
Neuropeptide Y immunoreactivity and NPY1R binding in the nucleus tractus solitarii (NTS) and paraventricular hypothalamic nucleus (PVN) of Wistar Kyoto (WKY) and spontaneously hypertensive (SHR) rats exposed either to nicotine or placebo delivered through subcutaneously implanted pellets during 8 weeks. Values are presented as mean ± SD, *P < 0.05 as compared to the same strain placebo-treated rat; #P < 0.05 as compared to WKY on the same experimental condition, according to 2-way ANOVA followed by Bonferroni posttest, n = 6.
See this image and copyright information in PMC

References

    1. Balakumar P, Kaur J. Is nicotine a key player or spectator in the induction and progression of cardiovascular disorders? Pharmacological Research. 2009;60(5):361–368. - PubMed
    1. Shinozaki N, Yuasa T, Takata S. Cigarette smoking augments sympathetic nerve activity in patients with coronary heart disease. International Heart Journal. 2008;49(3):261–272. - PubMed
    1. Westfall TC, Watts DT. The effect of nicotine on amines of brain and urine in the rat. Journal of Neurochemistry. 1964;11:397–402. - PubMed
    1. Ferrari MF, Fior-Chadi DR. Chronic nicotine administration. Analysis of the development of hypertension and glutamatergic neurotransmission. Brain Research Bulletin. 2007;72(4–6):215–224. - PubMed
    1. Haass M, Kubler W. Nicotine and sympathetic neurotransmission. Cardiovascular Drugs and Therapy. 1997;10(6):657–665. - PubMed

LinkOut - more resources